Sin categoría – Página 30 – SEIOMM, Sociedad Española de Investigación Ósea

Effects of abaloparatide on bone mineral density and risk of fracture in postmenopausal women aged 80 years or older with osteoporosis.

Menopause. 2018 Feb 16. doi: 10.1097/GME.0000000000001080. [Epub ahead of print]. McClung MR, Harvey NC, Fitzpatrick LA, Miller PD, Hattersley G, Wang Y, Cosman F. https://www.ncbi.nlm.nih.gov/pubmed/29462094

The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study.

J Bone Miner Res. 2018 Feb 22. doi: 10.1002/jbmr.3381. [Epub ahead of print] Turner DA, Khioe RFS, Shepstone L, Lenaghan E, Cooper C, Gittoes N, Harvey NC, Holland R, Howe A, McCloskey E, O’Neill TW, … Leer más

Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures: The EVOLVE Trial.

Neurosurgery. 2018 Mar 14. doi: 10.1093/neuros/nyy017. [Epub ahead of print] Beall DP, Chambers MR, Thomas S, Amburgy J, Webb JR Jr, Goodman BS, Datta DK, Easton RW, Linville D 2nd, Talati S, Tillman JB

Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates.

Calcif Tissue Int. 2018 Feb 14. doi: 10.1007/s00223-018-0404-6. [Epub ahead of print] Horne AM, Mihov B, Reid IR.

Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.

Bilezikian JP, Hattersley G, Fitzpatrick LA, Harris AG, Shevroja E, Banks K, Leder BZ, Zanchetta JR, Hans D. Osteoporos Int. 2018 Feb;29(2):323-328. doi: 10.1007/s00198-017-4304-9. Epub 2017 Nov 22.

Protective Effect of Denosumab on Bone in Older Women with Primary Hyperparathyroidism.

J Am Geriatr Soc. 2018 Jan 24. doi: 10.1111/jgs.15250 Eller-Vainicher C, Palmieri S, Cairoli E, Goggi G, Scillitani A, Arosio M, Falchetti A, Chiodini I. https://www.ncbi.nlm.nih.gov/pubmed/29364518

High Serum Retinol as a Relevant Contributor to Low Bone Mineral Density in Postmenopausal Osteoporotic Women.

Calcif Tissue Int. 2018 Jan 2. doi: 10.1007/s00223-017-0379-8. [Epub ahead of print] Navarro-Valverde C, Caballero-Villarraso J, Mata-Granados JM, Casado-Díaz A, Sosa-Henríquez M, Malouf-Sierra J, Nogués-Solán X, Rodríguez-Mañas L, Cortés-Gil X, Delgadillo-Duarte J, Quesada-Gómez JM.

Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial.

J Bone Miner Res. 2018 Jan 12. doi: 10.1002/jbmr.3384. [Epub ahead of print] Geusens P, Marin F, Kendler DL, Russo LA, Zerbini CA, Minisola S, Body JJ, Lespessailles E, Greenspan SL, Bagur A, Stepan JJ, … Leer más

Treatment-Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti-Resorptive Drugs: A Meta-Regression.

J Bone Miner Res. 2018 Jan 10. doi: 10.1002/jbmr.3355. [Epub ahead of print] Bauer DC, Black DM, Bouxsein ML, Lui LY, Cauley JA, de Papp AE, Grauer A, Khosla S, McCulloch CE, Eastell R; Foundation … Leer más

Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes.

Diabetes. 2018 Jan 4. pii: db170965. doi: 10.2337/db17-0965. [Epub ahead of print] Kalyanaraman H, Schwaerzer G, Ramdani G, Castillo F, Scott BT, Dillmann W, Sah RL, Casteel DE, Pilz RB. https://www.ncbi.nlm.nih.gov/pubmed/29301852